N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography

被引:27
|
作者
Schmidt, Paul
Pang, Dorothy
Nykamp, Diane
Knowlton, Gregory
Jia, Haomiao
机构
[1] St Josephs Hosp, Dept Nephrol, Atlanta, GA 30342 USA
[2] Mercer Univ, Coll Pharm & Hlth Sci, Dept Clin & Adm Sci, Atlanta, GA USA
[3] Mercer Univ, Sch Med, Atlanta, GA USA
关键词
N-acetylcysteine; radiocontrast-induced nephropathy; sodium bicarbonate;
D O I
10.1345/aph.1H354
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Radiocontrast-induced nephropathy (RCIN) is thought to be caused by renal ischemia and direct toxic effects on renal tubular cells brought on by contrast media. The combination of N-acetylcysteine (NAC) and hydration fluids (NaCl 0.9% or 0.45%) has been shown to reduce these deleterious effects and is commonly given prior to coronary angiography. The use of bicarbonate as the hydration anion has been shown to confer additional RCIN protection compared with that of saline. However, limited data are available regarding whether sodium bicarbonate hydration, proven to be beneficial alone, can further improve outcomes when given with NAC. OBJECTIVE: To compare the incidence of RCIN in patients undergoing coronary angiography from January 2002 to December 2005. Data were collected through electronic chart reviews. RESULTS: Forty-seven patients received NAC and sodium bicarbonate for hydration and 49 received NAC and standard hydration. Baseline characteristics between the 2 groups were similar. All patients received at least one 600 mg oral dose of NAC before before angiography was performed. RCIN was defined as impairment of renal function occurring within 72 hours of administering contrast media, indicated by an absolute increase in the serum creatinine level of 0.5 mg/dL or more. A total of 12.2% of the patients receiving NAC and standard hydration developed RCIN, versus 14.9% of the patients in the NAC and sodium bicarbonate group (p = 0.713). CONCLUSIONS: The addition of sodium bicarbonate to NAC does not appear to confer additional protection against the development of RCIN. Prospective, randomized, placebo-controlled trials are warranted to definitely determine how this combination compares with NAC and standard hydration in preventing RCIN.
引用
收藏
页码:46 / 50
页数:5
相关论文
共 50 条
  • [41] N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration
    Shalansky, SJ
    Pate, GE
    Levin, A
    Webb, JG
    HEART, 2005, 91 (08) : 997 - 999
  • [42] N-acetylcysteine in the prevention of ototoxicity
    Tepel, M.
    KIDNEY INTERNATIONAL, 2007, 72 (03) : 231 - 232
  • [43] A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy following coronary angiography.
    Caputo, C
    Dokko, JH
    Durham, JH
    Pahlavan, M
    Keltz, J
    Dutka, P
    Marzo, K
    Zaharakis, T
    Fishbane, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (04) : A14 - A14
  • [44] Prevention of contrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography:: A randomized multicenter trial
    Gomes, VO
    Caramori, P
    Lasevitch, R
    Brizolara, AA
    Nery, P
    Araújo, A
    Hemesath, M
    Brito, FS
    CIRCULATION, 2003, 108 (17) : 460 - 460
  • [45] N-acetylcysteine for the Prevention of Contrast-induced Nephropathy in the Emergency Department
    Hsu, Teh-Fu
    Huang, Ming-Kun
    Yu, Shao-Hua
    Yen, David Hung-Tsang
    Kao, Wei-Fong
    Chen, Ying-Chou
    Huang, Mu-Shun
    INTERNAL MEDICINE, 2012, 51 (19) : 2709 - 2714
  • [46] Intravenous N-Acetylcysteine in the Prevention of Contrast Media-Induced Nephropathy
    Anderson, Spencer M.
    Park, Zoon H.
    Patel, Ramesh V.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (01) : 101 - 107
  • [47] N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review
    Jo, Sang-Ho
    KOREAN CIRCULATION JOURNAL, 2011, 41 (12) : 695 - 702
  • [48] Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy.: A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures.: A single-center prospective controlled trial
    Ozcan, Einin E.
    Guneri, Seina
    Akdeniz, Bahri
    Akyildiz, Ilke Z.
    Senaslan, Omer
    Baris, Nezihi
    Aslan, Ozgur
    Badak, Ozer
    AMERICAN HEART JOURNAL, 2007, 154 (03) : 539 - 544
  • [49] N-Acetylcysteine to prevent contrast nephropathy
    Meine, TJ
    Washam, JB
    AMERICAN HEART JOURNAL, 2004, 147 (03) : 440 - 441
  • [50] Comparison of oral N-acetylcysteine versus intravenous sodium bicarbonate in contrast-induced nephropathy treatment [CONVICT Trial].
    Hill, S
    Fowler, S
    Sikand, H
    Phillips, P
    PHARMACOTHERAPY, 2005, 25 (10): : 1433 - 1433